Suven Pharmaceuticals Ltd.'s total assets for Q2 2026 were ₹55.68B, an increase of Infinity% from the previous quarter. IN:COHANCE total liabilities were ₹16.44B for the fiscal quarter, a -189.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.